Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 4, 2010, Pages 348-357

  Raphael, Jacob ^a   Gozal, Yaacov ^b,c   Navot, Nachum ^c   Zuo, Zhiyi ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Critical Care Medicine   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Heart; Hyperglycemia; Infarction; Postconditioning; Volatile anesthetics

Indexed keywords

CREATINE KINASE MB; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOFLURANE; NITRATE; NITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ANESTHETIC AGENT; GLUCOSE; GLUCOSE BLOOD LEVEL; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC ACID DERIVATIVE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMICS; HYPERGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; HEART INFARCTION; HEART MUSCLE; HEART RATE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANESTHETICS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CREATINE KINASE, MB FORM; GLUCOSE; HEART; HEART RATE; HYPERGLYCEMIA; ISOFLURANE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; SIGNAL TRANSDUCTION;

EID: 77951705916     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181d26583     Document Type: Article

References (48)

1. Lazar HL. Hyperglycemia during cardiac surgery. J Thorac Cardiovasc Surg. 2006;131:11-13.
2. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005; 130:1144.
3. Ishihara M, Inoue I, Kawagoe T, et al. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. Am J Cardiol. 2003;92:288-291. (Pubitemid 36897712)
4. Marfella R, Siniscalchi M, Esposito K, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care. 2003;26:3129-3135
5. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40:1748-1754.
6. Kersten JR, Orth KG, Pagel PS, et al. Role of adenosine in isofluraneinduced cardioprotection. Anesthesiology. 1997;86:1128-1139.
7. Kersten JR, Schmeling TJ, Pagel PS, et al. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87:361-370.
8. Novalija E, Kevin LG, Camara AK, et al. Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology. 2003;99:421-428.
9. Mullenheim J, Ebel D, Frassdorf J, et al. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology. 2002;96:934-940.
10. Pain T, Yang XM, Critz SD, et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87:460-466.
11. Raphael J, Abedat S, Rivo J, et al. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther. 2006;318:186-194.
12. Hausenloy DJ, Tsang A, Mocanu MM, et al. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol. 2005;288:H971-H976.
13. Raphael J, Zuo Z, Abedat S, et al. Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology. 2008;108:415-425.
14. Dawn B, Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci. 2002;962:18-41.
15. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285: H579-H588.
16. Chiari PC, Bienengraeber MW, Pagel PS, et al. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol- 3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology. 2005;102:102-109.
17. Chiari PC, Bienengraeber MW, Weihrauch D, et al. Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium. Anesthesiology. 2005;103: 74-83.
18. Krolikowski JG, Weihrauch D, Bienengraeber M, et al. Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anaesth. 2006;53:174-182.
19. Kehl F, Krolikowski JG, Mraovic B, et al. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002;96:183-188. (Pubitemid 34032499)
20. Kersten JR, Schmeling TJ, Orth KG, et al. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol. 1998;275:H721-H725.
21. Kehl F, Krolikowski JG, Weihrauch D, et al. N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology. 2003;98:1384-1390.
22. Tsang A, Hausenloy DJ, Mocanu MM, et al. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005;54: 2360-2364.
23. Drummond JC. MAC for halothane, enflurane, and isoflurane in the New Zealand white rabbit: And a test for the validity of MAC determinations. Anesthesiology. 1985;62:336-338.
24. Kersten JR, Montgomery MW, Ghassemi T, et al. Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol. 2001;280:H1744-H1750.
25. Guo Y, Jones WK, Xuan YT, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A. 1999;96:11507-11512.
26. Gilliam MB, Sherman MP, Griscavage JM, et al. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem. 1993;212:359-365.
27. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 1996;335: 1713-1720.
28. Schricker T, Carvalho G. Pro: tight perioperative glycemic control. J Cardiothorac Vasc Anesth. 2005;19:684-688.
29. McGirt MJ, Woodworth GF, Brooke BS, et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery. 2006;58: 1066-1073; discussion 73.
30. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078-3086.
31. Gross ER, LaDisa JF Jr, Weihrauch D, et al. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Physiol Heart Circ Physiol. 2003;284:H1552-H1559.
32. Kersten JR, Toller WG, Gross ER, et al. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol. 2000;278:H1218-H1224.
33. Tanaka K, Kehl F, Gu W, et al. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol. 2002;282: H2018-H2023.
34. Huhn R, Heinen A,Weber NC, et al. Hyperglycaemia blocks sevofluraneinduced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth. 2008;100:465-471.
35. Schricker T, Lattermann R, Fiset P, et al. Integrated analysis of protein and glucose metabolism during surgery: effects of anesthesia. J Appl Physiol. 2001;91:2523-2530.
36. Long CL, Spencer JL, Kinney JM, et al. Carbohydrate metabolism in normal man and effect of glucose infusion. J Appl Physiol. 1971;31:102-109.
37. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res. 2004;61:448-460.
38. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296: 1655-1657.
39. Varma S, Lal BK, Zheng R, et al. Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am J Physiol Heart Circ Physiol. 2005;289:H1744-H1751.
40. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology. 2004;100:707-721.
41. Jones SP, Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol. 2006;40:16-23.
42. Zhao G, Zhang X, Smith CJ, et al. Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. Am J Physiol. 1999;277:H268-H278.
43. Giugliano D, Marfella R, Coppola L, et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation. 1997;95:1783-1790.
44. Ebel D, Mullenheim J, Frassdorf J, et al. Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo. Pflugers Arch. 2003;446:175-182.
45. Srinivasan S, Hatley ME, Bolick DT, et al. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia. 2004;47:1727-1734.
46. Lee JH, Palaia T, Ragolia L. Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am J Physiol Cell Physiol. 2009;296:C327-C338.
47. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987;21:737-746.
48. Ramsay J, Shernan S, Fitch J, et al. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J Thorac Cardiovasc Surg. 2005;129:300-306.